TearLab Corp.

Company Website

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

TearLab Corp.

Market Cap as of 6/12/2015

$80,106,408

Market Cap as of 7/03/2014

$168,262,859

Market Cap as of 07/02/2013

$324,482,727

Market Cap as of 06/26/2012

$75,725,555

Market Cap as of 01/04/2012

$28,172,690

Market Cap as of 06/20/2011

$24,500,450

Market Cap as of 01/06/2011

$36,471,510

Exchange and Ticker Symbol

Nasdaq: TEAR

Fields of Research

Develops and commercializes TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease

Major Products

TearLab Osmolarity System

View all the companies in San Diego Publicly Traded Companies

TearLab Corp.

Market Cap as of 6/12/2015

Exchange

NASDAQ

Ticker

TEAR

Executives

Elias Vamvakas

  • Chairman
  • Chief Executive Officer

Similar Companies

Surgical and Medical Instrument Manufacturing339112
MEASURING AND CONTROLLING DEVICES, NOT ELSEWHERE CLASSIFIED3829
Surgical Appliance and Supplies Manufacturing339113
SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS3841